| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-09 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-09 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-09 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-08 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-08 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-08 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-08 |